ICAP participated in the Japan Promotion Meeting of Guangdong-Hong Kong-Macao Greater Bay Area
On April 9, the Guangdong-Hong Kong-Macao Greater Bay Area promotion meeting, organized by People’s Government of Guangdong Province, Government of Hong Kong Special Administrative Region and Government of the Macao Special Administrative Region, was held in Tokyo Imperial Hotel, to promote Guangdong-Hong Kong-Macao Greater Bay Area to global investors, especially the Japanese business community. Ma Xingrui, Governor of Guangdong province, Carrie Lam Cheng Yuet-ngor, Chief Executive of the Hong Kong Special Administrative Region, and Chen Haifan, Secretariat for Administration and Justice of Government of Macao Special Administrative Region attended the event and delivered keynote speeches.
The promotion meeting attracted thousands of guests, including statesmen, entrepreneurs and business leaders from the two countries. Cheng Yonghua, Chinese Ambassador Extraordinary and Plenipotentiary to Japan, Yoshihiro Seki, Vice Minister of Japan’s Ministry of Economy, Trade and Industry, Nobuhiko Sasaki, Director-general of Japan External Trade Organization and other officials attended the promotion meeting.
Zhang Chaomin (the first one from the right), Chairman of ICAP, at the Smart and health Forum of Guangdong-Hong Kong-Macao Greater Bay Area promotion meeting
At the forum, Zhang Chaomin, Chairman of ICAP, gave a discussion speech, sharing the opportunities of investment cooperation between Guangdong-Hong Kong-Macao Greater Bay Area and Japan in the comprehensive health industry.
Zhang Chaomin said that life science is one of the most important emerging industries in China in the future, and the comprehensive health industry will also become an important industry development direction in the Guangdong-Hong Kong-Macao Greater Bay Area. The comprehensive health industry is a great opportunity for cooperation between China and Japan, especially the Guangdong-Hong Kong-Macao Greater Bay Area and Japan. Japan is a world leader in pharmaceutical research and development, medical services as well as pension services. Rapid development and win-win can be achieved if combined with the large market and capital strength of the Greater Bay Area.
Zhang Chaomin (the third from the left on the back row), Chairman of ICAP, at the Guangdong-Hong Kong-Macao Greater Bay Area Tokyo Networking Dinner.
Guangzhou is one of the best regions to develop the foundation of the comprehensive health industry. Built by Kyoto University innovation capital and ICAP, the Sino-Japanese Biomedical Industrial Park will start construction in October this year and will become an important carrier to undertake the cooperation in life science fields such as innovative drugs, Chinese herbal medicine and medical devices from Japan into China.
Infinite Capital Holding Company (ICAP) is an enterprise organized by Guangzhou Municipal Government, and composed of 53 publically traded A-share listed companies in China including Wondfo, Hybio, Blueon, and Shangpin Home Collection. The shareholders are mainly from emerging industries in the field of bioscience, artificial intelligence and information technology.
The mission of ICAP is to be an emerging industrial service provider.
The business model of ICAP is to cooperate with listed companies in emerging industries to jointly invest in international emerging industries technology.
The business model of ICAP includes international technology investment bank, new industrial park and emerging industry fund.